Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan

Author:

Mimori Tsuneyo1,Harigai Masayoshi2,Atsumi Tatsuya3,Fujii Takao4,Kuwana Masataka5,Matsuno Hiroaki6,Momohara Shigeki78,Takei Syuji9,Tamura Naoto10,Takasaki Yoshinari11,Ikeuchi Satoshi12,Kushimoto Satoru13,Koike Takao14

Affiliation:

1. Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan,

2. Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan,

3. Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Hokkaido, Japan,

4. Department of Rheumatology and Clinical Immunology, Wakayama Medical University, Wakayama, Japan,

5. Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan,

6. Matsuno Clinic for Rheumatic Diseases, Toyama, Japan,

7. Hakkeikai Incorporated Medical Institution, Shizuoka, Japan,

8. Department of Orthopaedic Surgery, Keio University, Tokyo, Japan,

9. Department of Pediatric Rheumatology, Faculty of Medicine, School of Health Sciences, Medical Center for Children, Kagoshima University, Kagoshima, Japan,

10. Department of Internal Medicine and Rheumatology, Faculty of Medicine, Juntendo University, Tokyo, Japan,

11. Faculty of Medicine, Juntendo University Koshigaya Hospital, Juntendo University, Saitama, Japan,

12. Frontier PMS Section, Neurology Medical Department, Medical Division, Eisai Co, Ltd, Tokyo, Japan,

13. Post-Marketing Surveillance Group, Data Science and Administration Department, Toyama Chemical Co, Ltd, Tokyo, Japan, and

14. Sapporo Medical Center NTT EC, Hokkaido, Japan

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3